Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 18,500 shares at $35.12 ($650K) on 2026-09-02, disclosed to the SEC on 2026-09-04.
Scheduled sale ($650k) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |
| VERA | SELL | 2026-04-15 | $1.0M | — | Filing → |